INVO Fertility, Inc. Increase (Decrease) in Interest and Dividends Receivable
INVO Fertility, Inc. (IVF) reported Increase (Decrease) in Interest and Dividends Receivable of -$9.38 thousand for the 9-month period ending 2023-09-30, per its 10-Q filed 2023-11-13.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInInterestAndDividendsReceivable · last filed 2023-11-13
- INVO Fertility, Inc. increase (decrease) in interest and dividends receivable for the quarter ending 2023-09-30 was -$25.80K.
- INVO Fertility, Inc. increase (decrease) in interest and dividends receivable for the quarter ending 2023-06-30 was $9.10K.
- INVO Fertility, Inc. increase (decrease) in interest and dividends receivable for the quarter ending 2023-03-31 was $7.32K, a 6.69% increase year-over-year.
- INVO Fertility, Inc. increase (decrease) in interest and dividends receivable for the quarter ending 2022-12-31 was -$16.53K, a 175.74% decline year-over-year.
- INVO Fertility, Inc. increase (decrease) in interest and dividends receivable for fiscal 2022 was -$24.17K, a 207.90% decline from fiscal 2021.
- INVO Fertility, Inc. increase (decrease) in interest and dividends receivable for fiscal 2021 was $22.40K.
| Period end | Increase (Decrease) in Interest and Dividends Receivable 3 month | Increase (Decrease) in Interest and Dividends Receivable 3 month as first filed | Increase (Decrease) in Interest and Dividends Receivable 6 month | Increase (Decrease) in Interest and Dividends Receivable 9 month | Increase (Decrease) in Interest and Dividends Receivable 12 month |
|---|---|---|---|---|---|
| 2023-09-30 | -$25.80K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | -$16.70K derived: sum of 2 quarters · filed 2023-11-13 | -$9.38K 10-Q · filed 2023-11-13 | -$25.91K derived: sum of 4 quarters · filed 2023-11-13 | |
| 2023-06-30 | $9.10K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $16.42K 10-Q · filed 2023-08-14 | -$113.00 derived: sum of 3 quarters · filed 2023-08-14 | -$1.98K derived: sum of 4 quarters · filed 2023-11-13 | |
| 2023-03-31 | $7.32K 10-Q · filed 2023-05-15 | -$9.21K derived: sum of 2 quarters · filed 2023-05-15 | -$11.08K derived: sum of 3 quarters · filed 2023-11-13 | -$23.71K derived: sum of 4 quarters · filed 2023-11-13 | |
| 2022-12-31 | -$16.53K derived: 10-K 12 month − 10-Q 9 month · filed 2023-04-17 | -$18.39K derived: sum of 2 quarters · filed 2023-11-13 | -$31.03K derived: sum of 3 quarters · filed 2023-11-13 | -$24.17K 10-K · filed 2023-04-17 | |
| 2022-09-30 | -$1.86K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | -$14.50K derived: sum of 2 quarters · filed 2023-11-13 | -$7.64K 10-Q · filed 2023-11-13 | $14.18K derived: sum of 4 quarters · filed 2023-11-13 | |
| 2022-06-30 | -$12.63K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | -$5.78K 10-Q · filed 2023-08-14 | $16.05K derived: sum of 3 quarters · filed 2023-08-14 | $14.80K derived: sum of 4 quarters · filed 2023-08-14 | |
| 2022-03-31 | $6.86K 10-Q · filed 2023-05-15 | $28.68K derived: sum of 2 quarters · filed 2023-05-15 | $27.43K derived: sum of 3 quarters · filed 2023-05-15 | $29.10K derived: sum of 4 quarters · filed 2023-05-15 | |
| 2021-12-31 | $21.82K derived: 10-K 12 month − 10-Q 9 month · filed 2023-04-17 | $20.57K derived: sum of 2 quarters · filed 2023-04-17 | $22.24K derived: sum of 3 quarters · filed 2023-04-17 | $22.40K 10-K · filed 2023-04-17 | |
| 2021-09-30 | -$1.25K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $419.00 derived: sum of 2 quarters · filed 2022-11-14 | $579.00 10-Q · filed 2022-11-14 | ||
| 2021-06-30 | $1.67K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | $1.83K 10-Q · filed 2022-08-15 | |||
| 2021-03-31 | $160.00 10-Q · filed 2022-05-16 | -$160.00 10-Q · filed 2021-05-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| Tenon Medical, Inc. (TNON) | United States | $0.002B | |
| Profusa, Inc. (PFSA) | United States | $0.002B | |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B |